• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Korean Med Sci. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of th

tetano

Editor, Senior Moderator
J Korean Med Sci. 2020 Apr 6;35(13):e142. doi: 10.3346/jkms.2020.35.e142.
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.


Kim ES[SUP]#[/SUP][SUP]1[/SUP], Chin BS[SUP]#[/SUP][SUP]2[/SUP], Kang CK[SUP]3[/SUP], Kim NJ[SUP]3[/SUP], Kang YM[SUP]4[/SUP], Choi JP[SUP]5[/SUP], Oh DH[SUP]5[/SUP], Kim JH[SUP]6[/SUP], Koh B[SUP]7[/SUP], Kim SE[SUP]8[/SUP], Yun NR[SUP]9[/SUP], Lee JH[SUP]10[/SUP], Kim JY[SUP]11[/SUP], Kim Y[SUP]2[/SUP], Bang JH[SUP]12[/SUP], Song KH[SUP]1[/SUP], Kim HB[SUP]1[/SUP], Chung KH[SUP]13[/SUP], Oh MD[SUP]14[/SUP]; Korea National Committee for Clinical Management of COVID-19.

Author information




Abstract

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019. In this retrospective multicenter study, we investigated the clinical course and outcomes of novel coronavirus disease 2019 (COVID-19) from early cases in Republic of Korea.
METHODS:

All of the cases confirmed by real time polymerase chain reaction were enrolled from the 1st to the 28th patient nationwide. Clinical data were collected and analyzed for changes in clinical severity including laboratory, radiological, and virologic dynamics during the progression of illness.
RESULTS:

The median age was 40 years (range, 20-73 years) and 15 (53.6%) patients were male. The most common symptoms were cough (28.6%) and sore throat (28.6%), followed by fever (25.0%). Diarrhea was not common (10.7%). Two patients had no symptoms. Initial chest X-ray (CXR) showed infiltration in 46.4% of the patients, but computed tomography scan confirmed pneumonia in 88.9% (16/18) of the patients. Six patients (21.4%) required supplemental oxygen therapy, but no one needed mechanical ventilation. Lymphopenia was more common in severe cases. Higher level of C-reactive protein and worsening of chest radiographic score was observed during the 5-7 day period after symptom onset. Viral shedding was high from day 1 of illness, especially from the upper respiratory tract (URT).
CONCLUSION:

The prodromal symptoms of COVID-19 were mild and most patients did not have limitations of daily activity. Viral shedding from URT was high from the prodromal phase. Radiological pneumonia was common from the early days of illness, but it was frequently not evident in simple CXR. These findings could be plausible explanations for the easy and rapid spread of SARS-CoV-2 in the community.
? 2020 The Korean Academy of Medical Sciences.



KEYWORDS:

COVID-19; Cohort Study; Prognosis; Republic of Korea; SARS-CoV-2; Viral Pneumonia


PMID:32242348DOI:10.3346/jkms.2020.35.e142
 
Back
Top